Tal Zvi Zaks is Chief Medical Officer of Moderna, Inc.. Currently has a direct ownership of 0 shares of MRNA, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2020, when has been sold 15,000 shares (Common Stock) at a price of $15.68 per share, resulting in proceeds of $235,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Tal Zvi Zaks Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2020
BUY
Exercise of conversion of derivative security
$235,200 $15.68 p/Share
15,000 Added 50.0%
15,000 Common Stock
Sep 28 2020
SELL
Open market or private sale
$1,207,229 $70.2 p/Share
17,197 Reduced 100.0%
0 Common Stock
Sep 28 2020
BUY
Exercise of conversion of derivative security
$344,628 $20.04 p/Share
17,197 Added 50.0%
17,197 Common Stock
Sep 21 2020
SELL
Open market or private sale
$1,351,400 $67.57 p/Share
20,000 Reduced 100.0%
0 Common Stock
Sep 21 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock
Sep 14 2020
SELL
Open market or private sale
$1,247,317 $62.26 p/Share
20,034 Reduced 100.0%
0 Common Stock
Sep 14 2020
BUY
Exercise of conversion of derivative security
$362,615 $18.1 p/Share
20,034 Added 50.0%
20,034 Common Stock
Sep 08 2020
SELL
Open market or private sale
$1,490,621 $56.32 p/Share
26,467 Reduced 100.0%
0 Common Stock
Sep 08 2020
BUY
Exercise of conversion of derivative security
$440,146 $16.63 p/Share
26,467 Added 50.0%
26,467 Common Stock
Aug 31 2020
SELL
Open market or private sale
$1,939,500 $64.65 p/Share
30,000 Reduced 100.0%
0 Common Stock
Aug 31 2020
BUY
Exercise of conversion of derivative security
$498,900 $16.63 p/Share
30,000 Added 50.0%
30,000 Common Stock
Aug 24 2020
SELL
Open market or private sale
$1,636,250 $65.45 p/Share
25,000 Reduced 100.0%
0 Common Stock
Aug 24 2020
BUY
Exercise of conversion of derivative security
$435,750 $17.43 p/Share
25,000 Added 50.0%
25,000 Common Stock
Aug 17 2020
SELL
Open market or private sale
$1,381,200 $69.06 p/Share
20,000 Reduced 100.0%
0 Common Stock
Aug 17 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock
Aug 10 2020
SELL
Open market or private sale
$1,485,400 $74.27 p/Share
20,000 Reduced 100.0%
0 Common Stock
Aug 10 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock
Aug 03 2020
SELL
Open market or private sale
$1,497,800 $74.89 p/Share
20,000 Reduced 100.0%
0 Common Stock
Aug 03 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock
Jul 27 2020
SELL
Open market or private sale
$1,573,400 $78.67 p/Share
20,000 Reduced 100.0%
0 Common Stock
Jul 27 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock
Jul 20 2020
SELL
Open market or private sale
$1,689,800 $84.49 p/Share
20,000 Reduced 100.0%
0 Common Stock
Jul 20 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock
Jul 13 2020
SELL
Open market or private sale
$1,421,600 $71.08 p/Share
20,000 Reduced 100.0%
0 Common Stock
Jul 13 2020
BUY
Exercise of conversion of derivative security
$400,800 $20.04 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

ADAP
Adaptimmune Therapeutics PLC Healthcare
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare
TZZ

Tal Zvi Zaks

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA